首页> 外文OA文献 >RNomic identification and evaluation of npcTB_6715, a nonprotein-udcoding RNA gene as a potential biomarker for theuddetection of Mycobacterium tuberculosis
【2h】

RNomic identification and evaluation of npcTB_6715, a nonprotein-udcoding RNA gene as a potential biomarker for theuddetection of Mycobacterium tuberculosis

机译:Rnomic鉴定和评估npcTB_6715,一种非蛋白质- ud编码RNA基因作为潜在的生物标志物结核分枝杆菌的检测

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Technological advances in RNA biology greatly improved transcriptome profiling during the last two decades. Besides the discovery of manyudsmall RNAs (sRNA) that are involved in the physiological and pathophysiological regulation of various cellular circuits, it becomes evident thatudthe corresponding RNA genes might also serve as potential biomarkers to monitor the progression of disease and treatment. sRNA gene candidateudnpcTB_6715 was previously identified via experimental RNomic (unpublished data), and we report its application as potential biomarkerudfor the detection of Mycobacterium tuberculosis (MTB) in patient samples. For proof of principle, we developed a multiplex PCR assay andudreport its validation with 500 clinical cultures, positive for Mycobacteria. The analysis revealed 98.9% sensitivity, 96.1% specificity, positive andudnegative predictive values of 98.6% and 96.8%, respectively. These results underscore the diagnostic value of the sRNA gene as diagnosticudmarker for the specific detection of MTB in clinical samples. Its successful application and the general ease of PCR-based detection comparedudto standard bacterial culture techniques might be the first step towards ‘point-of-care’ diagnostics of Mycobacteria. To the best of our knowledge,udthis is the first time for the design of diagnostic applications based on sRNA genes, in Mycobacteria.
机译:在过去的二十年中,RNA生物学技术的进步极大地改善了转录组的分析。除了发现许多涉及各种细胞回路的生理和病理生理调控的超小RNA(sRNA)以外,很明显,相应的RNA基因也可能用作监测疾病和治疗进展的潜在生物标记。 sRNA基因候选物 udnpcTB_6715先前已通过实验性RNomic进行了鉴定(未发表的数据),我们报告了其作为检测患者样品中结核分枝杆菌(MTB)的潜在生物标志物的应用。为证明原理,我们开发了一种多重PCR分析方法,并报告了对分枝杆菌呈阳性的500种临床培养物的验证。分析显示灵敏度为98.9%,特异性为96.1%,阳性和阴性预测值分别为98.6%和96.8%。这些结果强调了sRNA基因作为诊断 udmarker对临床样品中MTB的特异性检测的诊断价值。与标准细菌培养技术相比,它的成功应用和基于PCR的检测的一般简便性可能是迈向分枝杆菌“即时诊断”诊断的第一步。据我们所知,这是首次在分枝杆菌中设计基于sRNA基因的诊断应用程序。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号